4 4 4 9
-
Federal regulators on Monday continued their crackdown on deceptive, ineffective weight-loss products, this time by filing a lawsuit against a company that threatened to enforce a so-called “gag clause” by imposing fines and filing lawsuits to stop customers from posting negative reviews and testimonials for the products online.
The Federal Trade Commission announced today that it filed a complaint against Roca Labs, Inc., Roca Labs Nutraceutical USA, Inc. and their principals for harming consumers by unfairly barring them from sharing truthful, negative comments about the company or its “Formula” and “Anti-Cravings” powder.
The products – which sold starting at $480 for a three- to four-month supply, bringing in more than $20 million since 2010 – were advertised online and through online search and social media advertising such as Google, Bing, Yahoo, and Facebook.
The company represented its products as safe and effective alternatives to gastric bypass surgery, claiming that users could lose as much as 21 pounds in one month, and that users have a 90% success rate in achieving substantial weight loss.
According to the FTC complaint [PDF], Roca Labs sued or threatened to sue consumers who shared their negative experiences online or complained to the Better Business Bureau.
The company claimed that these customers were in violation of a non-disparagement provision of the “Terms and Conditions” they supposedly agreed to when buying the products.
“Defendants have warned purchasers, through package inserts included in product shipments, that they agreed not to write any negative reviews about the Defendants or their products and would owe Defendants hundreds of dollars should they do so,” the FTC complaint states. “These practices… have caused or are likely to cause purchasers to refrain from commenting negatively about the Defendants or their products.”
Since 2014, the FTC claims that versions of the company’s terms include a “gag clause” purporting to prohibit customers from disparaging Roca Labs, its products and its employees.
“You agree that regardless of your personal experience with RL, you will not disparage RL and/or any of its employees, products or services,” the policy states. “This means that you will not speak, publish, cause to be published, print, review, blog, or otherwise write negatively about RL, or its products or employees in any way. This encompasses all forms of media, including and especially the internet.”
“If you breach this Agreement, as determined by RL in its sole discretion, all discounts will be waived and you agree to pay the full price for your product. In addition, we retain all legal rights and remedies against the breaching customer for breach of contract and any other appropriate causes of action.”
Roca Labs used testimonials and supposed third-party reviews to illustrate the weight-loss success consumers achieved with their products.
To do so, the company asked for “success videos” from purchasers by offering to pay 50% of the products’ price for providing positive reviews.
If customers posted negative reviews, the FTC claims, the company would claim that those users would owe the full price of the products, often totaling hundreds of dollars more than the advertised or actually paid price.
According to the FTC, in addition to threatening, fining and suing consumers, Roca Labs’ weight-loss claims are false and unsubstantiated. The FTC also charges that the defendants failed to disclose that they compensated users who posted positive reviews.
The FTC alleges that in some cases, the defendants violated consumers’ privacy by disclosing their personal health information to payment processors, banks, and in public court filings.
“Roca Labs had an adversarial relationship with the truth,” Jessica Rich, Director of the FTC’s Bureau of Consumer Protection, said in a statement. “Not only did they make false or unsubstantiated weight-loss claims, they also attempted to intimidate their own customers from sharing truthful – and truly negative – reviews of their products.”
ribbi |
|
Комментариев нет:
Отправить комментарий